Literature DB >> 21651938

Different patterns of expansion, contraction and memory differentiation of HIV-1 Gag-specific CD8 T cells elicited by adenovirus type 5 and modified vaccinia Ankara vaccines.

Vinod Kumar Bhaskara Pillai1, Sunil Kannanganat, Pablo Penaloza-Macmaster, Lakshmi Chennareddi, Harriet L Robinson, Jerry Blackwell, Rama Rao Amara.   

Abstract

The magnitude and functional quality of antiviral CD8 T cell responses are critical for the efficacy of T cell based vaccines. Here, we investigate the influence of two popular viral vectors, adenovirus type 5 (Ad5) and modified vaccinia Ankara (MVA), on expansion, contraction and memory differentiation of HIV-1 Gag insert-specific CD8 T cell responses following immunization and show different patterns for the two recombinant viral vectors. The Ad5 vector primed 6-fold higher levels of insert-specific CD8 effector T cells than the MVA vector. The Ad5-primed effector cells also underwent less contraction (<2-fold) than the MVA-primed cells (>5-fold). The Ad5-primed memory cells were predominantly CD62L negative (effector memory) whereas the MVA-primed memory cells were predominantly CD62L positive (central memory). Consistent with their memory phenotype, MVA-primed CD8 T cells underwent higher fold expansion than Ad5-primed CD8 T cells following a homologous or heterologous boost. Impressively, the Ad5 boost changed the quality of MVA-primed memory response such that they undergo less contraction with effector memory phenotype. However, the MVA boost did not influence the contraction and memory phenotype of Ad5-primed response. In conclusion, our results demonstrate that vaccine vector strongly influences the expansion, contraction and the functional quality of insert-specific CD8 T cell responses and have implications for vaccine development against infectious diseases.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21651938      PMCID: PMC3139022          DOI: 10.1016/j.vaccine.2011.05.083

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  43 in total

1.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.

Authors:  F Sallusto; D Lenig; R Förster; M Lipp; A Lanzavecchia
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

2.  Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes.

Authors:  N Manjunath; P Shankar; J Wan; W Weninger; M A Crowley; K Hieshima; T A Springer; X Fan; H Shen; J Lieberman; U H von Andrian
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

3.  Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

Authors:  R R Amara; F Villinger; J D Altman; S L Lydy; S P O'Neil; S I Staprans; D C Montefiori; Y Xu; J G Herndon; L S Wyatt; M A Candido; N L Kozyr; P L Earl; J M Smith; H L Ma; B D Grimm; M L Hulsey; J Miller; H M McClure; J M McNicholl; B Moss; H L Robinson
Journal:  Science       Date:  2001-04-06       Impact factor: 47.728

4.  Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells.

Authors:  A Langenkamp; M Messi; A Lanzavecchia; F Sallusto
Journal:  Nat Immunol       Date:  2000-10       Impact factor: 25.606

5.  Strength of stimulus and clonal competition impact the rate of memory CD8 T cell differentiation.

Authors:  Surojit Sarkar; Volker Teichgräber; Vandana Kalia; Antonio Polley; David Masopust; Laurie E Harrington; Rafi Ahmed; E John Wherry
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

6.  Human immunodeficiency virus type 1-specific immunity after genetic immunization is enhanced by modification of Gag and Pol expression.

Authors:  Y Huang; W P Kong ; G J Nabel
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

7.  Priming of memory but not effector CD8 T cells by a killed bacterial vaccine.

Authors:  G Lauvau; S Vijh; P Kong; T Horng; K Kerksiek; N Serbina; R A Tuma; E G Pamer
Journal:  Science       Date:  2001-11-23       Impact factor: 47.728

8.  Human immunodeficiency virus type 1 controllers but not noncontrollers maintain CD4 T cells coexpressing three cytokines.

Authors:  Sunil Kannanganat; Bill G Kapogiannis; Chris Ibegbu; Lakshmi Chennareddi; Paul Goepfert; Harriet L Robinson; Jeffrey Lennox; Rama Rao Amara
Journal:  J Virol       Date:  2007-08-29       Impact factor: 5.103

9.  Adenovirus type 5 induces vitamin A-metabolizing enzymes in dendritic cells and enhances priming of gut-homing CD8 T cells.

Authors:  S Ganguly; S Manicassamy; J Blackwell; B Pulendran; R R Amara
Journal:  Mucosal Immunol       Date:  2011-02-02       Impact factor: 7.313

10.  Migration and function of antigen-primed nonpolarized T lymphocytes in vivo.

Authors:  G Iezzi; D Scheidegger; A Lanzavecchia
Journal:  J Exp Med       Date:  2001-04-16       Impact factor: 14.307

View more
  16 in total

1.  Evaluation of non-reciprocal heterologous immunity between unrelated viruses.

Authors:  Jenny W Che; Liisa K Selin; Raymond M Welsh
Journal:  Virology       Date:  2015-03-31       Impact factor: 3.616

2.  Kinetic and phenotypic analysis of CD8+ T cell responses after priming with alphavirus replicons and homologous or heterologous booster immunizations.

Authors:  Maria Lisa Knudsen; Karl Ljungberg; Maria Kakoulidou; Linda Kostic; David Hallengärd; Juan García-Arriaza; Andres Merits; Mariano Esteban; Peter Liljeström
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

3.  Removal of vaccinia virus genes that block interferon type I and II pathways improves adaptive and memory responses of the HIV/AIDS vaccine candidate NYVAC-C in mice.

Authors:  Carmen Elena Gómez; Beatriz Perdiguero; Jose Luis Nájera; Carlos Oscar S Sorzano; Victoria Jiménez; Rubén González-Sanz; Mariano Esteban
Journal:  J Virol       Date:  2012-03-14       Impact factor: 5.103

4.  Modified vaccinia virus Ankara-based vaccine vectors induce apoptosis in dendritic cells draining from the skin via both the extrinsic and intrinsic caspase pathways, preventing efficient antigen presentation.

Authors:  E Guzman; C Cubillos-Zapata; M G Cottingham; S C Gilbert; H Prentice; B Charleston; J C Hope
Journal:  J Virol       Date:  2012-03-14       Impact factor: 5.103

5.  Antibodies to gp120 and PD-1 expression on virus-specific CD8+ T cells in protection from simian AIDS.

Authors:  Monica Vaccari; Rabih Halwani; L Jean Patterson; Adriano Boasso; Jennifer Beal; Elzbieta Tryniszewska; Anna Hryniewicz; David Venzon; Elias K Haddad; Mohamed El-Far; Margherita Rosati; George N Pavlakis; Barbara K Felber; Saleh Al-Muhsen; Marjorie Robert-Guroff; Rafick-Pierre Sekaly; Genoveffa Franchini
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

6.  Alternative serotype adenovirus vaccine vectors elicit memory T cells with enhanced anamnestic capacity compared to Ad5 vectors.

Authors:  Pablo Penaloza-MacMaster; Nicholas M Provine; Joshua Ra; Erica N Borducchi; Anna McNally; Nathaniel L Simmons; Mark J Iampietro; Dan H Barouch
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

Review 7.  Can immunotherapy be useful as a "functional cure" for infection with Human Immunodeficiency Virus-1?

Authors:  Guido Vanham; Ellen Van Gulck
Journal:  Retrovirology       Date:  2012-09-07       Impact factor: 4.602

Review 8.  OX40:OX40L axis: emerging targets for improving poxvirus-based CD8(+) T-cell vaccines against respiratory viruses.

Authors:  John Goulding; Vikas Tahiliani; Shahram Salek-Ardakani
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

9.  Organism-Level Analysis of Vaccination Reveals Networks of Protection across Tissues.

Authors:  Motohiko Kadoki; Ashwini Patil; Cornelius C Thaiss; Donald J Brooks; Surya Pandey; Deeksha Deep; David Alvarez; Ulrich H von Andrian; Amy J Wagers; Kenta Nakai; Tarjei S Mikkelsen; Magali Soumillon; Nicolas Chevrier
Journal:  Cell       Date:  2017-09-21       Impact factor: 66.850

10.  Heterologous prime-boost regimens using rAd35 and rMVA vectors elicit stronger cellular immune responses to HIV proteins than homologous regimens.

Authors:  Silvia Ratto-Kim; Jeffrey R Currier; Josephine H Cox; Jean-Louis Excler; Anais Valencia-Micolta; Doris Thelian; Vicky Lo; Eddy Sayeed; Victoria R Polonis; Patricia L Earl; Bernard Moss; Merlin L Robb; Nelson L Michael; Jerome H Kim; Mary A Marovich
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.